Alexander Schornstein - 22 Nov 2024 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Nov 2024, 09:15:02 UTC
Prior SEC filing
09 Oct 2024
Next SEC filing
10 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alexander Schornstein

Key filing fact

Alexander Schornstein filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 26 Nov 2024.

Key facts

  • This page summarizes Alexander Schornstein's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Nov 2024, 09:15.

Change

  • Previous filing in this sequence was filed on 09 Oct 2024.
  • Current net transaction value: +$371,994.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASMB transaction

Common Stock

Purchase

Transaction value
$253,104
Shares
+17,024
Change %
+2.4%
Price
$14.87
Shares after
720,137
Date
22 Nov 2024
Ownership
Direct
Footnotes
F1, F2
ASMB transaction

Common Stock

Purchase

Transaction value
$44,640
Shares
+2,976
Change %
+0.41%
Price
$15.00
Shares after
723,113
Date
25 Nov 2024
Ownership
Direct
Footnotes
F3, F4
ASMB transaction

Common Stock

Purchase

Transaction value
$74,250
Shares
+5,000
Change %
+0.69%
Price
$14.85
Shares after
728,113
Date
25 Nov 2024
Ownership
Direct
Footnotes
F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds.

Footnote F2

The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.

Footnote F3

The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.

Footnote F4

2,976 shares were purchased on November 25, 2024 at $15.00.

Footnote F5

The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.

Footnote F6

The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .